KTTA (STOCKS)
Pasithea Therapeutics Corp. Common Stock
$0.739900
+0.039900 (+5.70%)
Prev close: $0.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Tiago Reis Marques
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $18.72M
- Employees
- 4
- P/E (TTM)
- -0.21
- P/B (TTM)
- 0.29
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | $429.61K |
| Research and Development | $7.98M |
| Operating Income/Loss | -$20.86M |
| Income/Loss From Continuing Operations After Tax | -$20.43M |
| Income/Loss From Continuing Operations Before Tax | -$20.43M |
| Net Income/Loss | -$20.43M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$20.43M |
| Net Income/Loss Available To Common Stockholders, Basic | -$20.43M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.91 |
| Diluted Earnings Per Share | -$2.91 |
| Basic Average Shares | 7,031,050 |
| Diluted Average Shares | 7,031,050 |
| Assets | $60.24M |
| Current Assets | $56.46M |
| Prepaid Expenses | $811.46K |
| Other Current Assets | $55.65M |
| Noncurrent Assets | $3.78M |
| Intangible Assets | $2.90M |
| Other Non-current Assets | $880.99K |
| Liabilities | $5.02M |
| Current Liabilities | $4.97M |
| Noncurrent Liabilities | $46.87K |
| Equity | $55.22M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $55.22M |
| Liabilities And Equity | $60.24M |
| Net Cash Flow From Operating Activities | -$15.21M |
| Net Cash Flow From Operating Activities, Continuing | -$15.21M |
| Net Cash Flow From Investing Activities | $11.00K |
| Net Cash Flow From Investing Activities, Continuing | $11.00K |
| Net Cash Flow From Financing Activities | $63.52M |
| Net Cash Flow From Financing Activities, Continuing | $63.52M |
| Exchange Gains/Losses | $18.77K |
| Net Cash Flow | $48.34M |
| Net Cash Flow, Continuing | $48.32M |
| Comprehensive Income/Loss | -$20.41M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$20.41M |
| Other Comprehensive Income/Loss | -$20.41M |